- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Emricasan, formerly known as IDN-6556, in combination with birinapan is used to treat acute myeloid leukemia (AML). This small molecule irreversible inhibitor is under clinical investigation to reduce hepatic injury and liver fibrosis.
Antiapoptotic caspase inhibitor; Pan-Caspase Inhibitor
Emricasan is an antiapoptotic pan-caspase inhibitor. It has been in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) with advanced fibrosis (scarring) and cirrhosis. Emricasan has also been shown to protect infected astrocytes from ZIKV-induced cell death.
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| shipped in | wet ice |
| storage temp. | −20°C |
| SMILES string | CC(C)(C)C1=C(NC(C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(COC2=C(F)C(F)=CC(F)=C2F)=O)=O)=O)=O)C=CC=C1 |
| InChI | 1S/C26H27F4N3O7/c1-12(31-24(38)25(39)32-16-8-6-5-7-13(16)26(2,3)4)23(37)33-17(10-19(35)36)18(34)11-40-22-20(29)14(27)9-15(28)21(22)30/h5-9,12,17H,10-11H2,1-4H3,(H,31,38)(H,32,39)(H,33,37)(H,35,36)/t12-,17-/m0/s1 |
| InChI key | SCVHJVCATBPIHN-SJCJKPOMSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 4173.75
-
¥ 8293.41
-
询价
-
询价
-
询价
-
询价
-
¥ 9737.84
-
¥ 3152.47
-
¥ 3275.78
-
询价
-
¥ 3290.05
-
询价
-
¥ 4897.21
-
¥ 10277.12
-
¥ 1156.91
-
¥ 1783.21
-
询价
-
¥ 75435.65
-
¥ 18741.69
微信小程序
7X24小时在线咨询